1

Mini-antibodies Reactivate p53: New Potential Pathway for Cancer Therapy

News Discuss 
A major advance in cancer study is occurring with the use of mini-antibodies to re-engage damaged p53. This essential tumor protector protein is frequently inactivated in many kinds of malignancies, resulting https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story